Agarwal Arjun's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Aug 14, 2026
- Accession no.
- 0000907654-26-000075
- Filed
- Aug 14, 2026, 5:42 PM ET
- Trade date
- Aug 13, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.07M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agarwal ArjunCIK 0002033974 | Officer (Senior Vice President, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | MOption exerciseAcquired | +8,542 | $12.50 | +$106,775 | 23,854 | Direct | |
| Aug 13, 2026 | Common Stock | MOption exerciseAcquired | +1,458 | $34.39 | +$50,140.62 | 25,312 | Direct | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −2,100 | $104.67 | −$219,814.14 | 23,212 | Direct | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −2,132 | $105.57 | −$225,078.65 | 21,080 | Direct | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −1,268 | $106.63 | −$135,201.13 | 19,812 | Direct | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −2,142 | $107.71 | −$230,722.96 | 17,670 | Direct | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −2,358 | $108.46 | −$255,755.28 | 15,312 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | MOption exerciseDisposed | −8,542 | $0.00 | $0 | 92,917 | Direct | |
| Aug 13, 2026 | Common Stock | MOption exerciseDisposed | −1,458 | $0.00 | $0 | 59,792 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.